84845-75-0
84845-75-0
Chemical Structure
Niperotidine
- CAS No.: 84845-75-0
- Formula:C20H26N4O5S
- Molecular Weight:434.51
IUPAC Name: (E)-N-(benzo[d][1,3]dioxol-5-ylmethyl)-N'-(2-(((5-((dimethylamino)methyl)furan-2-yl)methyl)thio)ethyl)-2-nitroethene-1,1-diamine
InChIKey: HXRSXEDVVARPHP-NDENLUEZSA-N
SMILES: O=[N+](/C=C(NCCSCC1=CC=C(CN(C)C)O1)\NCC2=CC=C(OCO3)C3=C2)[O-]
Biological Activity: Niperotidine is a histamine H2-receptor antagonist.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Niperotidine | 98.90% | Niperotidine is a histamine H2-receptor antagonist. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ranitidine impurity 12 | Ranitidine impurity 12 is an impurity of Ranitidine. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ramixotidine | Ramisotidine is a histamine H2 receptor antagonist that can inhibit gastric acid secretion stimulated by pentagastrin. |
|||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ranitidine hydrochloride | 99.86% | Ranitidine hydrochloride is a potent, selective and orally active histamine H2-receptor antagonist that inhibits gastric secretion. Ranitidine hydrochloride antagonizes Histamine (HY-B1204)-induced increases of the guinea-pig isolated rat atrium and Histamine-induced relaxations of the rat isolated uterine horn, with pA2 values of 7.2 and 6.95, respectively. Ranitidine hydrochloride inhibits breast tumor development and spread in mice. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ranitidine-d6 hydrochloride | 97.00% | Ranitidine-d6 hydrochloride is the deuterium labeled Ranitidine hydrochloride (HY-B0281A). Ranitidine hydrochloride is a potent, selective and orally active histamine H2-receptor antagonist that inhibits gastric secretion. Ranitidine hydrochloride antagonizes Histamine (HY-B1204)-induced increases of the guinea-pig isolated rat atrium and Histamine-induced relaxations of the rat isolated uterine horn, with pA2 values of 7.2 and 6.95, respectively. Ranitidine hydrochloride inhibits breast tumor development and spread in mice. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ranitidine bismuth citrate | Ranitidine bismuth citrate is a potent, selective and orally active histamine H2-receptor antagonist that inhibits gastric secretion. Ranitidine bismuth citrate antagonizes Histamine (HY-B1204)-induced increases of the guinea-pig isolated rat atrium and Histamine-induced relaxations of the rat isolated uterine horn, with pA2 values of 7.2 and 6.95, respectively. Ranitidine bismuth citrate has selectivity for SARS-CoV-2-infected cells. Ranitidine bismuth citrate also has anti-Helicobacter pylori infection. Ranitidine bismuth citrate inhibits breast tumor development and spread in mice. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ranitidine-d6 | Ranitidine-d6 is the deuterium labeled Ranitidine (HY-B0693). Ranitidine is a potent, selective and orally active histamine H2-receptor antagonist that inhibits gastric secretion. Ranitidine antagonizes Histamine (HY-B1204)-induced increases of the guinea-pig isolated rat atrium and Histamine-induced relaxations of the rat isolated uterine horn, with pA2 values of 7.2 and 6.95, respectively. Ranitidine inhibits breast tumor development and spread in mice. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ranitidine S-oxide | Ranitidine S-oxide is the metabolite of Ranitidine (HY-B0693). Ranitidine is a potent, selective and orally active histamine H2-receptor antagonist with an IC50 of 3.3 μM that inhibits gastric secretion. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ranitidine impurity 15 | Ranitidine impurity 15 is an impurity of Ranitidine. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ranitidine impurity 8 | Ranitidine impurity 8 is an impurity of Ranitidine. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
